These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29678368)

  • 1. Psychopharmacotherapy of Attention Deficit-Hyperactivity Disorder in Children with Comorbid Conditions.
    Naguy A
    Pediatr Neurol; 2018 May; 82():7-12. PubMed ID: 29678368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric comorbidities in children with attention deficit hyperactivity disorder: implications for management.
    Pliszka SR
    Paediatr Drugs; 2003; 5(11):741-50. PubMed ID: 14580223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tics and Tourette syndrome.
    Shaw ZA; Coffey BJ
    Psychiatr Clin North Am; 2014 Sep; 37(3):269-86. PubMed ID: 25150562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Attention-Deficit/Hyperactivity Disorder with Medication in Children with Autism Spectrum Disorder With and Without Intellectual Disability: A DBPNet Study.
    Grater JE; Muniz EI; Silver EJ; Blum NJ; Shults J; Stein REK
    J Autism Dev Disord; 2023 Aug; 53(8):3144-3150. PubMed ID: 35633446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep disorders in children with Tourette syndrome.
    Ghosh D; Rajan PV; Das D; Datta P; Rothner AD; Erenberg G
    Pediatr Neurol; 2014 Jul; 51(1):31-5. PubMed ID: 24938137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanfacine Use in Children With Down Syndrome and Comorbid Attention-Deficit Hyperactivity Disorder (ADHD) With Disruptive Behaviors.
    Capone GT; Brecher L; Bay M
    J Child Neurol; 2016 Jul; 31(8):957-64. PubMed ID: 26936058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population.
    Radigan M; Lannon P; Roohan P; Gesten F
    J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):44-56. PubMed ID: 15741785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder.
    Rappley MD; Eneli IU; Mullan PB; Alvarez FJ; Wang J; Luo Z; Gardiner JC
    J Dev Behav Pediatr; 2002 Feb; 23(1):23-30. PubMed ID: 11889348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders.
    Steingard R; Biederman J; Spencer T; Wilens T; Gonzalez A
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):350-3. PubMed ID: 8444764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention deficit disorder.
    Weaver A
    Br J Psychiatry; 1996 Oct; 169(4):523. PubMed ID: 8894209
    [No Abstract]   [Full Text] [Related]  

  • 11. Comorbidity with ADHD decreases response to pharmacotherapy in children and adolescents with acute mania: evidence from a metaanalysis.
    Consoli A; Bouzamondo A; Guilé JM; Lechat P; Cohen D
    Can J Psychiatry; 2007 May; 52(5):323-8. PubMed ID: 17542383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists.
    Yamamuro K; Tsujii N; Ota T; Kishimoto T; Iida J
    Psychiatry Clin Neurosci; 2017 Aug; 71(8):554-561. PubMed ID: 28317224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep characteristics of children and adolescents with attention deficit-hyperactivity disorder.
    Gruber R
    Child Adolesc Psychiatr Clin N Am; 2009 Oct; 18(4):863-76. PubMed ID: 19836693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders.
    Biederman J; Newcorn J; Sprich S
    Am J Psychiatry; 1991 May; 148(5):564-77. PubMed ID: 2018156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary: considerations on the pharmacotherapy of attention deficits and hyperactivity in children with autism and other pervasive developmental disorders.
    Nicolson R; Castellanos FX
    J Autism Dev Disord; 2000 Oct; 30(5):461-2. PubMed ID: 11098884
    [No Abstract]   [Full Text] [Related]  

  • 16. Tic Severity and Treatment in Children: The Effect of Comorbid Attention Deficit Hyperactivity Disorder and Obsessive Compulsive Behaviors.
    Pringsheim T
    Child Psychiatry Hum Dev; 2017 Dec; 48(6):960-966. PubMed ID: 28289952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotropic Drug Treatment Patterns in Persons with Fragile X Syndrome.
    Dominick KC; Andrews HF; Kaufmann WE; Berry-Kravis E; Erickson CA
    J Child Adolesc Psychopharmacol; 2021 Dec; 31(10):659-669. PubMed ID: 34818076
    [No Abstract]   [Full Text] [Related]  

  • 18. Attention-deficit/hyperactivity disorder: etiology and pharmacotherapy.
    Noorbala AA; Akhondzadeh S
    Arch Iran Med; 2006 Oct; 9(4):374-80. PubMed ID: 17061613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social behavior and comorbidity in children with tics.
    Pringsheim T; Hammer T
    Pediatr Neurol; 2013 Dec; 49(6):406-10. PubMed ID: 24095577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders].
    Wiesegger G; Kienbacher C; Pellegrini E; Scheidinger H; Vesely C; Bangerl W; Friedrich M
    Neuropsychiatr; 2007; 21(3):187-206. PubMed ID: 17915180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.